Johnson & Johnson beat EPS estimates 100% of the time across 20 reported quarters (20 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22027 FY2027 | $2.84 | $2.90 | +2.1% | Beat |
| Q12027 FY2027 | $2.67 | $2.70 | +1.1% | Beat |
| Q42026 FY2026 | $2.43 | $2.46 | +1.2% | Beat |
| Q42025 FY2025 | $1.99 | $2.04 | +2.5% | Beat |
| Q42024 FY2024 | $2.27 | $2.29 | +0.9% | Beat |
| Q3 FY2023 | $2.52 | $2.66 | +5.6% | Beat |
| Q2 FY2023 | $2.61 | $2.80 | +7.3% | Beat |
| Q1 FY2023 | $2.51 | $2.68 | +6.8% | Beat |
| Q42023 FY2023 | $2.22 | $2.35 | +5.9% | Beat |
| Q32023 FY2023 | $2.49 | $2.55 | +2.4% | Beat |
| Q22023 FY2023 | $2.57 | $2.59 | +0.8% | Beat |
| Q12023 FY2023 | $2.60 | $2.67 | +2.7% | Beat |
Back to JNJ overview · JNJ holders · JNJ KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.